MaxCyte, Inc. (MXCT) Tops Q1 EPS by 4c

MaxCyte, Inc. (NASDAQ: MXCT) reported Q1 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.3 million.

For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.

You May Also Be Interested In

• Citigroup (C) Tops Q2 EPS by 42c
• Wolfe Research on Bank of America (BAC): 'we expect shares to lag modestly in today’s session'
• Barclays on JPMorgan (JPM): 'expenses and tax rate were higher than anticipated'